Hypovolemic shock: microcirculatory changes during and after specific therapy.
D000804:Angiotensin II / Q000627:therapeutic use; D000818:Animals; D001775:Blood Circulation; D001793:Blood Preservation; D001803:Blood Transfusion; D002196:Capillaries; D004285:Dogs; D008638:Mesenteric Arteries; D008642:Mesenteric Veins; D008680:Metaraminol / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use*; D012771:Shock, Hemorrhagic / Q000628:therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D010952:Plasma Substitutes; D013566:Sympathomimetics; D014665:Vasodilator Agents; D010643:Phenoxybenzamine; D000804:Angiotensin II; D008680:Metaraminol; D009638:Norepinephrine